Matches in SemOpenAlex for { <https://semopenalex.org/work/W45119724> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W45119724 endingPage "116" @default.
- W45119724 startingPage "95" @default.
- W45119724 abstract "The pathogenesis, epidemiology, clinical features, sequelae, and treatment of bronchiolitis are reviewed. Acute bronchiolitis is the most common severe lower-respiratory-tract infection of infancy. During epidemics, more than 80% of cases may be caused by respiratory syncytial virus (RSV). Although signs and symptoms may become severe, most infections are self-limited and improvement occurs within several days. Approximately 1-2% of infants less than one year of age require hospitalization. Generally, patients who develop severe, life-threatening RSV bronchiolitis are those with underlying cardiopulmonary disease, immunosuppression, bronchopulmonary dysplasia, or a history of premature birth. In severe bronchiolitis, necrosis of the respiratory epithelium, excessive mucus production, and lymphocytic infiltration result in edema, dense plugs of debris, and subsequent bronchiolar obstruction. IgE-mediated reactions and release of inflammatory mediators may result in exacerbation of acute obstruction and may contribute to chronic obstructive pulmonary dysfunction, a common sequela of bronchiolitis. Patients hospitalized with bronchiolitis usually require supportive therapy and may require mechanical ventilation. Based on recent data, a trial of aerosolized beta 2 agonists is warranted in all patients. Systemic corticosteroids have not proved efficacious and have a limited role in the treatment of acute bronchiolitis. Inhaled corticosteroids may be useful in reducing the severity of chronic wheezing that may follow acute bronchiolitis. Ribavirin may be considered in patients with severe illness or in those at high risk for severe RSV disease. Intravenous immune globulin may have a role in the treatment of lower-respiratory-tract infections involving RSV; however, since few studies have been performed in humans, it is not possible to determine its place in the treatment of bronchiolitis. A trial of aerosolized beta 2 agonists is warranted in patients with bronchiolitis. Ribavirin may be considered in patients with severe disease or those at high risk for severe disease." @default.
- W45119724 created "2016-06-24" @default.
- W45119724 creator A5059603961 @default.
- W45119724 creator A5087651724 @default.
- W45119724 date "1993-02-01" @default.
- W45119724 modified "2023-09-23" @default.
- W45119724 title "Pathogenesis and treatment of bronchiolitis." @default.
- W45119724 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8095871" @default.
- W45119724 hasPublicationYear "1993" @default.
- W45119724 type Work @default.
- W45119724 sameAs 45119724 @default.
- W45119724 citedByCount "23" @default.
- W45119724 countsByYear W451197242015 @default.
- W45119724 countsByYear W451197242016 @default.
- W45119724 countsByYear W451197242017 @default.
- W45119724 countsByYear W451197242022 @default.
- W45119724 crossrefType "journal-article" @default.
- W45119724 hasAuthorship W45119724A5059603961 @default.
- W45119724 hasAuthorship W45119724A5087651724 @default.
- W45119724 hasConcept C126322002 @default.
- W45119724 hasConcept C141071460 @default.
- W45119724 hasConcept C203014093 @default.
- W45119724 hasConcept C2522874641 @default.
- W45119724 hasConcept C2776178081 @default.
- W45119724 hasConcept C2777014857 @default.
- W45119724 hasConcept C2777609351 @default.
- W45119724 hasConcept C2777714996 @default.
- W45119724 hasConcept C2778376644 @default.
- W45119724 hasConcept C2778721537 @default.
- W45119724 hasConcept C2778821649 @default.
- W45119724 hasConcept C2779234561 @default.
- W45119724 hasConcept C2779644171 @default.
- W45119724 hasConcept C2780942790 @default.
- W45119724 hasConcept C534529494 @default.
- W45119724 hasConcept C54355233 @default.
- W45119724 hasConcept C71924100 @default.
- W45119724 hasConcept C86803240 @default.
- W45119724 hasConceptScore W45119724C126322002 @default.
- W45119724 hasConceptScore W45119724C141071460 @default.
- W45119724 hasConceptScore W45119724C203014093 @default.
- W45119724 hasConceptScore W45119724C2522874641 @default.
- W45119724 hasConceptScore W45119724C2776178081 @default.
- W45119724 hasConceptScore W45119724C2777014857 @default.
- W45119724 hasConceptScore W45119724C2777609351 @default.
- W45119724 hasConceptScore W45119724C2777714996 @default.
- W45119724 hasConceptScore W45119724C2778376644 @default.
- W45119724 hasConceptScore W45119724C2778721537 @default.
- W45119724 hasConceptScore W45119724C2778821649 @default.
- W45119724 hasConceptScore W45119724C2779234561 @default.
- W45119724 hasConceptScore W45119724C2779644171 @default.
- W45119724 hasConceptScore W45119724C2780942790 @default.
- W45119724 hasConceptScore W45119724C534529494 @default.
- W45119724 hasConceptScore W45119724C54355233 @default.
- W45119724 hasConceptScore W45119724C71924100 @default.
- W45119724 hasConceptScore W45119724C86803240 @default.
- W45119724 hasIssue "2" @default.
- W45119724 hasLocation W451197241 @default.
- W45119724 hasOpenAccess W45119724 @default.
- W45119724 hasPrimaryLocation W451197241 @default.
- W45119724 hasRelatedWork W1969148298 @default.
- W45119724 hasRelatedWork W2002985785 @default.
- W45119724 hasRelatedWork W2065264417 @default.
- W45119724 hasRelatedWork W2067718647 @default.
- W45119724 hasRelatedWork W2161945259 @default.
- W45119724 hasRelatedWork W2314943952 @default.
- W45119724 hasRelatedWork W2365243221 @default.
- W45119724 hasRelatedWork W2593174835 @default.
- W45119724 hasRelatedWork W45119724 @default.
- W45119724 hasRelatedWork W953524167 @default.
- W45119724 hasVolume "12" @default.
- W45119724 isParatext "false" @default.
- W45119724 isRetracted "false" @default.
- W45119724 magId "45119724" @default.
- W45119724 workType "article" @default.